REViV is a minimally manipulated human tissue allograft derived from the amniotic fluid and the extracellular matrix of the amniotic membrane. REViV is for homologous use and is intended to regulate and maintain tissue regenerative processes.

The extracellular matrix of REViV contains a high concentration of cellular scaffolding, cytokines, growth factors, and proteins. The extracellular matrix(ECM) is a collection of extracellular molecules that provide the structural support needed for surrounding cells. Amniotic ECM is comprised of collagens, multi-adhesive glycoproteins, elastic, glycosaminoglycans, growth factors, and cytokines.

Why REViV?

  • REViV components are intended to reduce inflammation and continue the healing process, improving, or in some cases, eliminating your pain.
  • REViV is immune-privileged; the risk of rejection is extremely rare.
  • For in-office procedures, there is minimal, if any, downtime after treatment.
  • REViV is typically a one-time treatment compared to corticosteroids which mask the pain by shutting down the body's nerves in a specific area. Relief with steroids does begin right away but it does not last and there are significant side-effects from long term use.
  • REViV is recovered from healthy, carefully screened mothers at the time of cesarean section. All protocols are in accordance with the FDA and the American Association of Tissue Banks (AATB) regulations and standard. REViV is regulated as a human cell, tissue, or cellular or tissue-based product (HCT/P) under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

Potential Treatment Areas:

  • Aesthetics
  • Back Pain
  • Cartilage Damage
  • Degenerated Joints
  • Joint Dysfunction
  • Knee Injuries
  • Ligament Tears
  • Meniscus Damage
  • Muscle Tears
  • Nerve Injury
  • Rotator Cuff Injury
  • Tendon Tears

Quality Assurance

REViV™ is processed from donated amniotic fluid and membrane from full-term deliveries. All donors are pre-screened and undergo comprehensive testing that includes:

  • Behavioral risk assessment
  • Physical assessment
  • Donor medical history
  • Communicable disease testing


  • HBsAg
  • HBcAb
  • HCV
  • HIV I/II-Ab